Leveraging the advances in HIV for COVID-19

Lancet. 2020 Oct 3;396(10256):943-944. doi: 10.1016/S0140-6736(20)32012-2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines
  • Antiviral Agents / therapeutic use
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / prevention & control*
  • Global Health
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy
  • HIV Infections / prevention & control*
  • Humans
  • Pandemics / prevention & control*
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / prevention & control*
  • Risk Factors
  • SARS-CoV-2
  • Vulnerable Populations

Substances

  • AIDS Vaccines
  • Antiviral Agents